gemini advisors & consultants inc.

3 frost court
new city, new york 10956

NYS Entity Status
ACTIVE

NYS Filing Date
JANUARY 08, 2014

NYS DOS ID#
4510246

County
ROCKLAND

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC BUSINESS CORPORATION

Name History
2014 - GEMINI ADVISORS & CONSULTANTS INC.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Women of Sex Tech, Unite
    By ANNA NORTH - Friday Aug 18, 2017

    New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.

    Source: NYT > Home Page
  • The Look: New York City Parks in the Summer: Romance, Games and a Performance for a Dying Tree
    By DANIEL ARNOLD, JOANNA NIKAS and EVE LYONS - Saturday Sep 2, 2017

    Daniel Arnold spent the last two months photographing parks in all five boroughs. The experience showed him “a very different pulse of the city.”

    Source: NYT > Home Page
  • Inside New York City’s Priciest Rentals
    By CAROLINE BIGGS - Friday Sep 1, 2017

    Some New Yorkers could afford to buy multimillion-dollar properties, but they’d rather rent a place for upward of $20,000 a month.

    Source: NYT > Home Page
  • Priceline, TripAdvisor Cut Revenue, Hotel Bookings Forecasts
    Wednesday Aug 9, 2017

    Shares of Priceline Group Inc. fell after the online travel company cut forecasts for growth in hotel bookings. TripAdvisor Inc. shares initially swooned after it also said revenue growth would slow, but rebounded by the end of the trading day.

    Source: The Wall Street Journal: U.S. Business
  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy VC, Deals, & Startups Feed
gemini advisors amp consultants inc new city ny